{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T17:30:43Z","timestamp":1790962243798,"version":"4.1.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.saa.2023.122715","type":"journal-article","created":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T18:25:33Z","timestamp":1680719133000},"page":"122715","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Eco-friendly-assessed micellar-fluorimetric platform for concurrent analysis of empagliflozin and prucalopride succinate in biological fluids: Docking simulation"],"prefix":"10.1016","volume":"296","author":[{"given":"Israa M.","family":"Nour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed R.","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed A.","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Badrawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.saa.2023.122715_b0005","first-page":"38","article-title":"Dipeptidyl peptidase-4 inhibitors and glucagon like peptide-1 analogs: New founds for type 2 diabetes mellitus","volume":"2","author":"Tikoo","year":"2012","journal-title":"Int. J. Basic Appl. Med. Sci."},{"issue":"1","key":"10.1016\/j.saa.2023.122715_b0010","first-page":"S4","article-title":"Standards of medical care in diabetes","volume":"28","author":"Clausen","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.saa.2023.122715_b0015","doi-asserted-by":"crossref","unstructured":"The Diabetes Control and Complications Trial Research Group, The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New Eng. J. Med. 329, 14 (1993), 977-986.","DOI":"10.1056\/NEJM199309303291401"},{"issue":"16","key":"10.1016\/j.saa.2023.122715_b0020","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1001\/archinte.161.16.1989","article-title":"Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15 000 adults","volume":"161","author":"Bytzer","year":"2001","journal-title":"Arch. Intern. Med."},{"issue":"3","key":"10.1016\/j.saa.2023.122715_b0025","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/j.1572-0241.2002.05537.x","article-title":"GI symptoms in diabetes mellitus are associated with both poor glycemic control and diabetic complications","volume":"97","author":"Bytzer","year":"2002","journal-title":"Am. J. Gastroenterol."},{"issue":"11","key":"10.1016\/j.saa.2023.122715_b0030","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1023\/A:1026657426396","article-title":"Pilot study of pathophysiology of constipation among community diabetics","volume":"43","author":"Maleki","year":"1998","journal-title":"Dig. Dis. Sci."},{"issue":"1","key":"10.1016\/j.saa.2023.122715_b0035","doi-asserted-by":"crossref","first-page":"e13958","DOI":"10.1111\/nmo.13958","article-title":"Prucalopride in diabetic and connective tissue disease-related gastroparesis: randomized placebo-controlled crossover pilot trial","volume":"33","author":"Andrews","year":"2021","journal-title":"Neurogastroenterol. Motil."},{"issue":"1","key":"10.1016\/j.saa.2023.122715_b0040","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s13300-014-0063-1","article-title":"The SGLT2 inhibitor empagliflozin for the treatment of type 2 diabetes mellitus: a bench to bedside review","volume":"5","author":"McGill","year":"2014","journal-title":"Diabetes Therapy"},{"key":"10.1016\/j.saa.2023.122715_b0045","article-title":"Empagliflozin: a new sodium-glucose co-transporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes","volume":"3","author":"Neumiller","year":"2014","journal-title":"Drugs in Context"},{"issue":"1","key":"10.1016\/j.saa.2023.122715_b0050","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1463-1326.2011.01517.x","article-title":"Empagliflozin, a novel selective sodium glucose cotransporter-2 (SGLT-2) inhibitor: characterisation and comparison with other SGLT-2 inhibitors","volume":"14","author":"Grempler","year":"2012","journal-title":"Diabetes Obes. Metab."},{"issue":"1","key":"10.1016\/j.saa.2023.122715_b0055","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0014-2999(01)01087-1","article-title":"The in vitro pharmacological profile of prucalopride, a novel enterokinetic compound","volume":"423","author":"Briejer","year":"2001","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.saa.2023.122715_b0060","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1365-2036.2011.04907.x","article-title":"Randomised clinical trial: the efficacy of prucalopride in patients with chronic intestinal pseudo-obstruction\u2013a double-blind, placebo-controlled, cross-over, multiple n= 1 study","volume":"35","author":"Emmanuel","year":"2012","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"8","key":"10.1016\/j.saa.2023.122715_b0065","doi-asserted-by":"crossref","first-page":"e508","DOI":"10.1111\/j.1463-1318.2011.02929.x","article-title":"The successful treatment of acute refractory pseudo-obstruction with prucalopride","volume":"14","author":"Smart","year":"2012","journal-title":"Colorectal disease: the official journal of the Association of Coloproctology of Great Britain and Ireland"},{"issue":"5","key":"10.1016\/j.saa.2023.122715_b0070","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1136\/gut.44.5.682","article-title":"Selective stimulation of colonic transit by the benzofuran 5HT4 agonist, prucalopride, in healthy humans","volume":"44","author":"Bouras","year":"1999","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.saa.2023.122715_b0075","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1053\/gast.2001.21166","article-title":"Prucalopride accelerates gastrointestinal and colonic transit in patients with constipation without a rectal evacuation disorder","volume":"120","author":"Bouras","year":"2001","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.saa.2023.122715_b0080","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1136\/gut.2008.162404","article-title":"Prucalopride (Resolor) in the treatment of severe chronic constipation in patients dissatisfied with laxatives","volume":"58","author":"Tack","year":"2009","journal-title":"Gut"},{"key":"10.1016\/j.saa.2023.122715_b0085","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1007\/s10895-022-02942-1","article-title":"Utility of Silver-nanoparticles for Nano-fluorimetric Determination of Vancomycin Hydrochloride in Pharmaceutical Formulation and Biological Fluids: Greenness Assessment","volume":"32","author":"Mohamed","year":"2022","journal-title":"J. Fluoresc."},{"issue":"2","key":"10.1016\/j.saa.2023.122715_b0090","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/bio.3417","article-title":"Utility of cremophor RH 40 as a micellar improvement for spectrofluorimetric estimation of sorafenib in pure form, commercial preparation, and human plasma","volume":"33","author":"Zidan","year":"2018","journal-title":"Luminescence"},{"issue":"1","key":"10.1016\/j.saa.2023.122715_b0095","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/bio.3406","article-title":"A novel spectrofluorimetric method for determination of imatinib in pure, pharmaceutical preparation, human plasma, and human urine","volume":"33","author":"Zidan","year":"2018","journal-title":"Luminescence"},{"key":"10.1016\/j.saa.2023.122715_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2020.120944","article-title":"Analysis of various solid samples by synchronous fluorescence spectroscopy and related methods: A review","volume":"216","author":"Samokhvalov","year":"2020","journal-title":"Talanta"},{"issue":"10","key":"10.1016\/j.saa.2023.122715_b0105","article-title":"Synchronous fluorescence as a green and selective tool for simultaneous determination of bambuterol and its main degradation product","volume":"5","author":"Abo El Abass","year":"2018","journal-title":"terbutaline Royal Society open science"},{"key":"10.1016\/j.saa.2023.122715_b0110","article-title":"Green fitted second derivative synchronous spectrofluorometric msethod for simultaneous determination of remdesivir and apixaban at Nano gram scale in the spiked human plasma","volume":"290","author":"Batubara","year":"2022","journal-title":"Spectrochim. Acta A Mol. Biomol. Spectrosc."},{"key":"10.1016\/j.saa.2023.122715_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.saa.2023.122442","article-title":"Micellar-enhanced and green-assessed first-derivative synchronous spectrofluorimetric approach for concurrent determination of alfuzosin hydrochloride and solifenacin succinate in different matrices: Docking simulation","volume":"293","author":"Sayed","year":"2023","journal-title":"Spectrochim. Acta A Mol. Biomol. Spectrosc."},{"issue":"6","key":"10.1016\/j.saa.2023.122715_b0120","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/bio.2828","article-title":"Micelle-enhanced spectrofluorimetric determination of amlexanox in bioadhesive buccal tablets: application to content uniformity testing","volume":"30","author":"Walash","year":"2015","journal-title":"Luminescence"},{"key":"10.1016\/j.saa.2023.122715_b0125","article-title":"Green chromatographic methods for simultaneous micro-determination of empagliflozin, linagliptin with metformin and its pharmacopoeial impurities in pure form and triple combination tablets: A comparative study","volume":"25","author":"El-Kafrawy","year":"2022","journal-title":"Sustain. Chem. Pharm."},{"issue":"6","key":"10.1016\/j.saa.2023.122715_b0130","doi-asserted-by":"crossref","DOI":"10.1098\/rsos.220215","article-title":"Analytical quality by design based on design space in reversed-phase-high performance liquid chromatography analysis for simultaneous estimation of metformin, linagliptin and empagliflozin","volume":"9","author":"Marie","year":"2022","journal-title":"R. Soc. Open Sci."},{"key":"10.1016\/j.saa.2023.122715_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.microc.2020.105795","article-title":"Determination of empagliflozin in the presence of its organic impurities and identification of two degradation products using UHPLC-QTOF\/MS","volume":"161","author":"Manoel","year":"2021","journal-title":"Microchem. J."},{"issue":"12","key":"10.1016\/j.saa.2023.122715_b0140","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1007\/s10337-020-03962-4","article-title":"Stability indicating, pH and pKa dependent HPLC\u2013DAD method for the simultaneous determination of weakly ionizable Empagliflozin, dapagliflozin and canagliflozin in pharmaceutical formulations","volume":"83","author":"Sharif","year":"2020","journal-title":"Chromatographia"},{"issue":"3","key":"10.1016\/j.saa.2023.122715_b0145","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.26452\/ijrps.v11i3.2583","article-title":"Stability indicating assay method for the simultaneous estimation of empagliflozin and metformin HCL by RP-HPLC method","volume":"11","author":"Reddy","year":"2020","journal-title":"Int. J. Res. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.saa.2023.122715_b0150","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1177\/1469066719879297","article-title":"Development of simultaneous determination of empagliflozin and metformin in human plasma using liquid chromatography\u2013mass spectrometry and application to pharmacokinetics","volume":"26","author":"Wattamwar","year":"2020","journal-title":"Eur. J. Mass Spectrom."},{"issue":"12","key":"10.1016\/j.saa.2023.122715_b0155","doi-asserted-by":"crossref","first-page":"7313","DOI":"10.1039\/C9RA08442H","article-title":"The application of quality by design in the development of the liquid chromatography method to determine empagliflozin in the presence of its organic impurities","volume":"10","author":"Manoel","year":"2020","journal-title":"RSC Adv."},{"issue":"4","key":"10.1016\/j.saa.2023.122715_b0160","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1556\/1006.2019.32.4.4","article-title":"Simultaneous estimation of empagliflozin and metformin by high-performance thin-layer chromatography using quality-by-design approach","volume":"32","author":"Thakor","year":"2019","journal-title":"JPC\u2013J. Planar Chromatograp. Modern TLC"},{"issue":"7","key":"10.1016\/j.saa.2023.122715_b0165","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1093\/chromsci\/bmx030","article-title":"LC\u2013MS\/MS determination of empagliflozin and metformin","volume":"55","author":"Ayoub","year":"2017","journal-title":"J. Chromatogr. Sci."},{"issue":"3","key":"10.1016\/j.saa.2023.122715_b0170","doi-asserted-by":"crossref","first-page":"669","DOI":"10.12991\/marupj.323590","article-title":"Mean centering method for determination of empagliflozin and metformin","volume":"21","author":"Ayoub","year":"2017","journal-title":"Marmara Pharmaceutical Journal"},{"key":"10.1016\/j.saa.2023.122715_b0175","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.saa.2016.06.010","article-title":"Development and validation of simple spectrophotometric and chemometric methods for simultaneous determination of empagliflozin and metformin: Applied to recently approved pharmaceutical formulation","volume":"168","author":"Ayoub","year":"2016","journal-title":"Spectrochim. Acta A Mol. Biomol. Spectrosc."},{"key":"10.1016\/j.saa.2023.122715_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.saa.2021.119609","article-title":"Simple mathematical data processing method for the determination of sever overlapped spectra of linagliptin and empagliflozin in their pure forms and pharmaceutical formulation: Fourier self deconvulated method","volume":"254","author":"Elmasry","year":"2021","journal-title":"Spectrochim. Acta A Mol. Biomol. Spectrosc."},{"issue":"5","key":"10.1016\/j.saa.2023.122715_b0185","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1002\/bio.3491","article-title":"Liquid chromatographic and spectrofluorimetric assays of empagliflozin: applied to degradation kinetic study and content uniformity testing","volume":"33","author":"Abdel-Ghany","year":"2018","journal-title":"Luminescence"},{"key":"10.1016\/j.saa.2023.122715_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.saa.2020.118307","article-title":"New spectrofluorimetric analysis of empagliflozin in its tablets and human plasma using two level full factorial design","volume":"235","author":"Omar","year":"2020","journal-title":"Spectrochim. Acta A Mol. Biomol. Spectrosc."},{"key":"10.1016\/j.saa.2023.122715_b0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.saa.2020.119258","article-title":"Flourimetric study on antidiabetic combined drugs; empagliflozin and linagliptin in their pharmaceutical formulation and human plasma","volume":"248","author":"Elmasry","year":"2021","journal-title":"Spectrochim. Acta A Mol. Biomol. Spectrosc."},{"issue":"4","key":"10.1016\/j.saa.2023.122715_b0200","first-page":"6","article-title":"Thermo analytical study and purity determination of Anti-diabetic drugs Linagliptin and Empagliflozin in drug substances","volume":"5","author":"Rizk","year":"2020","journal-title":"Chem. Res. J."},{"issue":"8","key":"10.1016\/j.saa.2023.122715_b0205","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1002\/elan.202000007","article-title":"Validated Voltammetric Method for the Simultaneous Determination of Anti-diabetic Drugs, Linagliptin and Empagliflozin in Bulk, Pharmaceutical Dosage Forms and Biological Fluids","volume":"32","author":"Rizk","year":"2020","journal-title":"Electroanalysis"},{"key":"10.1016\/j.saa.2023.122715_b0210","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jpba.2016.03.047","article-title":"Selective separation and characterisation of stress degradation products and process impurities of prucalopride succinate by LC-QTOF-MS\/MS","volume":"125","author":"Mahamuni","year":"2016","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.saa.2023.122715_b0215","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.jchromb.2016.09.006","article-title":"Development and validation of a sensitive UHPLC\u2013MS\/MS method for quantitation of prucalopride in rat plasma and its application to pharmacokinetics study","volume":"1033","author":"Sun","year":"2016","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.saa.2023.122715_b0220","first-page":"510","article-title":"Implementation of Quality by Design Approach for Analytical Method Development and Validation for Estimation of Prucalopride Succinate in the Bulk and Solid Dosage Form","volume":"11","author":"Chawathe","year":"2020","journal-title":"J. Pharm. Quality Assurance"},{"key":"10.1016\/j.saa.2023.122715_b0225","first-page":"166","article-title":"Development And Validation Of A Stability Indicating Rp-Hplc Method For The Determination Of Prucalopride Succinate In Bulk And Tablet","volume":"12","author":"Kanthale","year":"2020","journal-title":"VHL Regional Portal, Information and Knowledge for Health"},{"key":"10.1016\/j.saa.2023.122715_b0230","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1080\/22297928.2021.1911680","article-title":"A Validated Stability-Indicating Method for Separation of Prucalopride Drug by HPLC: Method Transfer to UPLC","volume":"11","author":"Makwana","year":"2021","journal-title":"Anal. Chem. Lett."},{"key":"10.1016\/j.saa.2023.122715_b0235","doi-asserted-by":"crossref","first-page":"39","DOI":"10.26463\/rjps.11_3_6","article-title":"New Analytical RP-HPLC Method Development and Validation for the Estimation of Prucalopride in Bulk and Pharmaceutical Dosage Form","volume":"11","author":"Sreedhar","year":"2021","journal-title":"RGUHS J. Pharm. Sci."},{"key":"10.1016\/j.saa.2023.122715_b0240","article-title":"An eco-friendly method for voltametric determination of prucalopride succinate on simple nanoparticles modified carbon paste electrode","volume":"66","author":"Eleryan","year":"2022","journal-title":"Egypt. J. Chem."},{"key":"10.1016\/j.saa.2023.122715_b0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.measurement.2022.112071","article-title":"A portable solid-contact potentiometric sensor based on zeolite-carbon paste for assay of prucalopride succinate in tablet dosage form: Green profile assessment","volume":"204","author":"Elshahed","year":"2022","journal-title":"Measurement"},{"issue":"4","key":"10.1016\/j.saa.2023.122715_b0250","first-page":"1568","article-title":"UV spectrophotometric method for estimation of prucalopride succinate in pharmaceutical dosage form","volume":"9","author":"Akhani","year":"2020","journal-title":"World J. Pharm. Res."},{"key":"10.1016\/j.saa.2023.122715_b0255","doi-asserted-by":"crossref","first-page":"4189","DOI":"10.52711\/0974-360X.2021.00725","article-title":"Analytical method development and validation of prucalopride succinate in bulk and formulation by UV-Visible spectrophotometry","volume":"14","author":"Bhosale","year":"2021","journal-title":"Res. J. Pharm. Technol."},{"key":"10.1016\/j.saa.2023.122715_b0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13065-022-00876-0","article-title":"Novel sensing probe using Terbium-sensitized luminescence and 8-hydroxyquinoline for determination of prucalopride succinate: green assessment with Complex-GAPI and analytical Eco-Scale","volume":"16","author":"Elshahed","year":"2022","journal-title":"BMC Chem."},{"key":"10.1016\/j.saa.2023.122715_b0265","unstructured":"ICH, Q2 (R1): Validation of analytical procedures: text and methodology. In International Conference on Harmonization, Geneva (2005)."},{"issue":"7","key":"10.1016\/j.saa.2023.122715_b0270","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/dom.12073","article-title":"Safety, tolerability, pharmacokinetics and pharmacodynamics following 4 weeks' treatment with empagliflozin once daily in patients with type 2 diabetes","volume":"15","author":"Heise","year":"2013","journal-title":"Diabetes Obes. Metab."},{"issue":"11","key":"10.1016\/j.saa.2023.122715_b0275","doi-asserted-by":"crossref","first-page":"797","DOI":"10.5414\/CP201769","article-title":"Pharmacokinetics of single and repeated oral doses of prucalopride in healthy Chinese volunteers","volume":"50","author":"Chen","year":"2012","journal-title":"Int. J. Clin. Pharm. Therap."},{"issue":"1","key":"10.1016\/j.saa.2023.122715_b0280","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1080\/17518253.2018.1431313","article-title":"The EcoScale as a framework for undergraduate green chemistry teaching and assessment","volume":"11","author":"Dicks","year":"2018","journal-title":"Green Chem. Lett. Rev."},{"issue":"15","key":"10.1016\/j.saa.2023.122715_b0285","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1039\/C6AY00478D","article-title":"Metrics for green analytical chemistry","volume":"8","author":"Tobiszewski","year":"2016","journal-title":"Anal. Methods"}],"container-title":["Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386142523004006?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386142523004006?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T02:30:59Z","timestamp":1761359459000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386142523004006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":57,"alternative-id":["S1386142523004006"],"URL":"https:\/\/doi.org\/10.1016\/j.saa.2023.122715","relation":{},"ISSN":["1386-1425"],"issn-type":[{"value":"1386-1425","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Eco-friendly-assessed micellar-fluorimetric platform for concurrent analysis of empagliflozin and prucalopride succinate in biological fluids: Docking simulation","name":"articletitle","label":"Article Title"},{"value":"Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.saa.2023.122715","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"122715"}}